Comparison of Substance Use Milestones in Cannabis- and Cocaine-Dependent Patients

Jonathan T. Horey MD Division on Substance Abuse, New York Psychiatric Institute, New York, New York, USA; Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York, New York, USA

John J. Mariani MD Division on Substance Abuse, New York Psychiatric Institute, New York, New York, USA; Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York, New York, USA

Wendy Y. Cheng MPH Division on Substance Abuse, New York Psychiatric Institute, New York, New York, USA; Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York, New York, USA

Adam Bisaga MD Division on Substance Abuse, New York Psychiatric Institute, New York, New York, USA; Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York, New York, USA

Maria Sullivan MD Division on Substance Abuse, New York Psychiatric Institute, New York, New York, USA; Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York, New York, USA

Edward Nunes MD Division on Substance Abuse, New York Psychiatric Institute, New York, New York, USA; Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York, New York, USA

Frances R. Levin MD Division on Substance Abuse, New York Psychiatric Institute, New York, New York, USA; Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York, New York, USA

show all

Abstract

Objectives: To compare the progression of substance use milestones between cocaine- and cannabis-dependent patients. Methods: Using data gathered from two separate clinical studies for treatment of cocaine dependence and cannabis dependence, 130 cannabis-dependent and 112 cocaine-dependent individuals were compared on milestones related to their substance use. Results: In cannabis- vs. cocaine-dependent patients, the mean age of first use, regular use and first treatment contact differed significantly. No statistically significant differences were found between the two groups for other measured milestones. Conclusions: These results differ from most epidemiologic studies that suggest cocaine users progress more rapidly to regular use and treatment contact.

KEYWORDS:

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Comparison of Substance Use Milestones in Cannabis- and Cocaine-Dependent Patients

Information for

Open access

Opportunities

Help and information

Comparison of Substance Use Milestones in Cannabis- and Cocaine-Dependent Patients

Abstract

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature